FDA
label_change
· 2013-01-11
FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
Summary
The FDA approved a supplemental application for OxyContin (oxycodone hydrochloride) from Purdue Pharma to update the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXYCONTIN (OXYCODONE HYDROCHLORIDE)